Profil Pasien COVID-19 dengan Hipertensi di RS Lapangan Indrapura Surabaya

Muchammad Alydrus, Erwin Astha Triyono, Wardah Rahmatul Islamiyah

Sari


ABSTRACT

 

Coronavirus Disease 2019 (COVID-19) is a type of disease caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2).  Hypertension is one of the comorbidities that can exacerbate COVID-19 in patients. This study aims to determine the profile of patient with COVID-19 and hypertension to support appropriate clinical management for these patients can be determined. A retrospective study was conducted to review the medical records of COVID-19 patients with hypertension who were treated at Indrapura Field Hospital in Surabaya during February - August 2021. Of the 3997 COVID-19 patients treated at the Indrapura Field Hospital, Surabaya for the period February - August 2021 the final sample obtained was 575 COVID-19 patients with hypertension (14,39%).  Two hundred and twenty-three (38,8%) were female patients and 352 (61,2%) were male patients.  The mean age is 47.2 years.  Most of the patients (209, 36,3%) were aged 41-50. The most common nutritional status in patients was Obesity I, found in 225 patients (39,1%).  Three hundred and sixty-one patients (62,8%) were self-employed.  COVID-19 patients with hypertension were classified as mild in 394 (68,5%). From all COVID-19 patients with hypertension, 540 recovered from their disease (93,3%).  The most frequently found clinical symptom was cough in 248 patients (43,1%) and vitamins were the most symptomatic therapy given to 572 patients (99,5%).  Type I hypertension was found in the most in patients, namely 258 patients (44,9%) and 426 patients received therapy, namely monotherapy (74,1%).  Another comorbidity that was found the most in patients COVID-19 with hypertension was diabetes (48, 8,3%).

Conclusion: Of the 3997 COVID-19 patients who were treated at RS Lapangan Indrapura in Surabaya for the period February - August 2021, 575 patients were found to have comorbid hypertension. The majority of COVID-19 patients with comorbid hypertension are male in the age range of 41-50 and the clinical degree is mild and suffers from clinical symptoms such as coughing.

 

Keywords: COVID-19, Hypertension, Profile. 

 

ABSTRAK

 

Coronavirus Disease 2019 (COVID-19) merupakan jenis penyakit yang disebabkan oleh severe acute respiratory syndrome coronavirus (SARS-CoV-2). Hipertensi menjadi salah satu komorbid yang dapat memperparah pasien COVID-19.  Penelitian ini bertujuan untuk mengetahui profil penderita COVID-19 dengan hipertensi sehingga bermanfaat untuk menentukan tatalaksana yang tepat bagi pasien. Studi retrospektif dilakukan untuk mengkaji rekam medis pasien COVID-19 dengan hipertensi yang dirawat di RS Lapangan Indrapura Surabaya selama Februari – Agustus 2021.Dari 3997 pasien COVID-19 yang dirawat di RS Lapangan Indrapura Surabaya ditemukan 575 pasien dengan komorbid hipertensi (14,39%). Dua ratus dua puluh tiga (38,8%) adalah pasien wanita dan 352 (61,2%) adalah pasien laki-laki. Usia rata-rata adalah 47,2 tahun. Sebagian besar pasien (209, 36,3%) termasuk dalam usia 41-50. Status gizi paling banyak pada pasien adalah obesitas I yaitu 225 pasien (39,1%) dan 361 pasien (62,8%) bekerja sebagai wiraswasta. Pasien COVID-19 dengan hipertensi yang tergolong ringan sebanyak 394 (68,5%) dan seluruh pasien COVID-19 dengan hipertensi, sebanyak 540 (93,3%) sembuh. Gejala klinis paling banyak ditemukan adalah batuk yaitu 248 pasien (43,1%) dan vitamin merupakan terapi simptomatik yang paling banyak diberikan kepada 572 pasien (99,5%). Hipertensi tipe I paling banyak ditemukan pada pasien, yaitu 258 pasien (44,9%) dan sebanyak 426 pasien mendapatkan terapi yaitu monoterapi (74,1%). Komorbid lain yang ditemukan paling banyak pada pasien COVID-19 dengan hipertensi adalah diabetes (48, 8,3%). Dari 3997 pasien COVID-19 yang dirawat di RS Lapangan Indrapura Surabaya periode Februari - Agustus 2021  ditemukan 575 pasien dengan komorbid hipertensi. Mayoritas pasien COVID-19 dengan komorbid hipertensi berjenis kelamin laki-laki dalam rentang usia 41-50 dan derajat klinis ringan serta menderita gejala klinis berupa batuk.

 

Kata Kunci: COVID-19, Hipertensi, Profil


Kata Kunci


COVID-19;hipertensi;profil

Teks Lengkap:

Download Artikel

Referensi


Abdelghani, M., Hamed, M. G., Said, A., & Fouad, E. (2022). Evaluation Of Perceived Fears Of Covid-19 Virus Infection And Its Relationship To Health-Related Quality Of Life Among Patients With Diabetes Mellitus In Egypt During Pandemic: A Developing Country Single-Center Study. Diabetology International, 13(1), 108–116. Https://Doi.Org/10.1007/S13340-021-00511-8

Akbariqomi, M., Hosseini, M. S., Rashidiani, J., Sedighian, H., Biganeh, H., Heidari, R., Moghaddam, M. M., Farnoosh, G., & Kooshki, H. (2020). Clinical Characteristics And Outcome Of Hospitalized Covid-19 Patients With Diabetes: A Single-Center, Retrospective Study In Iran. Diabetes Research And Clinical Practice, 169, 108467. Https://Doi.Org/10.1016/J.Diabres.2020.108467

Aqmarina, N. W., Risanti, E. D., Mahmudah, I. N. N., & Jatmiko, S. W. (2021). Obesitas Sebagai Faktor Risiko Keparahan Pada Covid-19. Prosiding University Research Colloquium, 371–377.

Bialek, S., Boundy, E., Bowen, V., Chow, N., Cohn, A., Dowling, N., Ellington, S., Gierke, R., Hall, A., Macneil, J., Patel, P., Peacock, G., Pilishvili, T., Razzaghi, H., Reed, N., Ritchey, M., & Sauber-Schatz, E. (2020). Severe Outcomes Among Patients With Coronavirus Disease 2019 (Covid-19) — United States, February 12–March 16, 2020. Mmwr. Morbidity And Mortality Weekly Report, 69(12), 343–346. Https://Doi.Org/10.15585/Mmwr.Mm6912e2

Burhan, E., Susanto, A. D., Nasution, S. A., Ginanjar, E., Pitoyo, C. W., Susilo, A., Firdaus, I., Santoso, A., Juzar, D. A., Arif, S. K., Lolong Wulung, N. G., Adityaningsih, D., Syam, A. F., Rasmin, M. I., & Sambo, C. M. (2020). Pedoman Tatalaksana Covid-19 Edisi 3 Tim Editor Perhimpunan Dokter Paru Indonesia (Pdpi) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (Perki) Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (Papdi) Perhimpunan Dokter Anestesiologi Dan Terapi Intensif Indonesia (Perdatin) Ikatan Dokter Anak Indonesia (Idai).

Choirunnisa, C., & Helda, H. (2021). Hubungan Hipertensi Dengan Mortalitas Pasien Covid-19 Di Tangerang Selatan. Jurnal Epidemiologi Kesehatan Indonesia, 5(2). Https://Doi.Org/10.7454/Epidkes.V5i2.5265

Driggin, E., Maddox, T. M., Ferdinand, K. C., Kirkpatrick, J. N., Ky, B., Morris, A. A., Mullen, J. B., Parikh, S. A., Philbin, D. M., & Vaduganathan, M. (2021). Acc Health Policy Statement On Cardiovascular Disease Considerations For Covid-19 Vaccine Prioritization. Journal Of The American College Of Cardiology, 77(15), 1938–1948. Https://Doi.Org/10.1016/J.Jacc.2021.02.017

Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., He, J., Liu, L., Shan, H., Lei, C., Hui, D. S. C., Du, B., Li, L., Zeng, G., Yuen, K.-Y., Chen, R., Tang, C., Wang, T., Chen, P., Xiang, J., … Zhong, N. (2020). Clinical Characteristics Of Coronavirus Disease 2019 In China. New England Journal Of Medicine, 382(18), 1708–1720. Https://Doi.Org/10.1056/Nejmoa2002032

Gunawan, A., Prahasanti, K., & Utama, M. R. (2020). Pengaruh Komorbid Hipertensi Terhadap Severitas Pasien Yang Terinfeksi Covid-19. Jurnal Implementa Husada, 1(2), 136. Https://Doi.Org/10.30596/Jih.V1i2.4972

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical Features Of Patients Infected With 2019 Novel Coronavirus In Wuhan, China. The Lancet, 395(10223), 497–506. Https://Doi.Org/10.1016/S0140-6736(20)30183-5

Lestari, N., & Ichsan, B. (2021). Diabetes Melitus Sebagai Faktor Risiko Keparahan Dan Kematian Pasien Covid-19: Meta-Analisis. Biomedika, 13(1), 83–94. Https://Doi.Org/10.23917/Biomedika.V13i1.13544

Letko, M., Marzi, A., & Munster, V. (2020). Functional Assessment Of Cell Entry And Receptor Usage For Sars-Cov-2 And Other Lineage B Betacoronaviruses. Nature Microbiology, 5(4), 562–569. Https://Doi.Org/10.1038/S41564-020-0688-Y

Levani, Y., Prastya, A. D., & Mawaddatunnadila, S. (2021). Coronavirus Disease 2019 (Covid-19): Patogenesis, Manifestasi Klinis Dan Pilihan Terapi. Jurnal Kedokteran Dan Kesehatan, 17(1), 44. Https://Doi.Org/10.24853/Jkk.17.1.44-57

Linelejan, B., Umboh, O., & Wantania, F. E. N. (2021). Pengaruh Penggunaan Angiotensin Converting Enzyme Inhibitor (Acei) Dan Angiotensin Receptor Blocker (Arb) Pada Pasien Coronavirus Disease 2019 (Covid-19) Dengan Hipertensi. E-Clinic, 9(1). Https://Doi.Org/10.35790/Ecl.V9i1.31963

Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J. (2016). Global Disparities Of Hypertension Prevalence And Control. Circulation, 134(6), 441–450. Https://Doi.Org/10.1161/Circulationaha.115.018912

Parohan, M., Yaghoubi, S., Seraji, A., Javanbakht, M. H., Sarraf, P., & Djalali, M. (2020). Risk Factors For Mortality In Patients With Coronavirus Disease 2019 (Covid-19) Infection: A Systematic Review And Meta-Analysis Of Observational Studies. The Aging Male, 23(5), 1416–1424. Https://Doi.Org/10.1080/13685538.2020.1774748

Peña, J. E. La, Rascón-Pacheco, R. A., Ascencio-Montiel, I. De J., González-Figueroa, E., Fernández-Gárate, J. E., Medina-Gómez, O. S., Borja-Bustamante, P., Santillán-Oropeza, J. A., & Borja-Aburto, V. H. (2021). Hypertension, Diabetes And Obesity, Major Risk Factors For Death In Patients With Covid-19 In Mexico. Archives Of Medical Research, 52(4), 443–449. Https://Doi.Org/10.1016/J.Arcmed.2020.12.002

Rahayu, L. A. D., Admiyanti, J. C., Khalda, Y. I., Ahda, F. R., Agistany, N. F. F., Setiawati, S., Shofiyanti, N. I., & Warnaini, C. (2021). Hipertensi, Diabetes Melitus, Dan Obesitas Sebagai Faktor Komorbiditas Utama Terhadap Mortalitas Pasien Covid-19: Sebuah Studi Literatur. Jimki: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 9(1), 90–97. Https://Doi.Org/10.53366/Jimki.V9i1.342

Rashedi, J., Mahdavi Poor, B., Asgharzadeh, V., Pourostadi, M., Samadi Kafil, H., Vegari, A., Tayebi-Khosroshahi, H., & Asgharzadeh, M. (2020). Risk Factors For Covid-19. Le Infezioni In Medicina, 28(4), 469–474.

Seo, G., Lee, G., Kim, M. J., Baek, S.-H., Choi, M., Ku, K. B., Lee, C.-S., Jun, S., Park, D., Kim, H. G., Kim, S.-J., Lee, J.-O., Kim, B. T., Park, E. C., & Kim, S. Il. (2020). Rapid Detection Of Covid-19 Causative Virus (Sars-Cov-2) In Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor. Acs Nano, 14(4), 5135–5142. Https://Doi.Org/10.1021/Acsnano.0c02823

Susilo, A., Rumende, C. M., Pitoyo, C. W., Santoso, W. D., Yulianti, M., Herikurniawan, H., Sinto, R., Singh, G., Nainggolan, L., Nelwan, E. J., Chen, L. K., Widhani, A., Wijaya, E., Wicaksana, B., Maksum, M., Annisa, F., Jasirwan, C. O. M., & Yunihastuti, E. (2020). Coronavirus Disease 2019: Tinjauan Literatur Terkini. Jurnal Penyakit Dalam Indonesia, 7(1), 45. Https://Doi.Org/10.7454/Jpdi.V7i1.415

Sylvestris, A. (2017). Hipertensi Dan Retinopati Hipertensi. Saintika Medika, 10(1), 1. Https://Doi.Org/10.22219/Sm.V10i1.4142

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical Characteristics Of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia In Wuhan, China. Jama, 323(11), 1061. Https://Doi.Org/10.1001/Jama.2020.1585

Willim, H. A., Ketaren, I., & Supit, A. I. (2020). Dampak Coronavirus Disease 2019 Terhadap Sistem Kardiovaskular. E-Clinic, 8(2). Https://Doi.Org/10.35790/Ecl.V8i2.30540

Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020). High Expression Of Ace2 Receptor Of 2019-Ncov On The Epithelial Cells Of Oral Mucosa. International Journal Of Oral Science, 12(1), 8. Https://Doi.Org/10.1038/S41368-020-0074-X

Yang, J., Hu, J., & Zhu, C. (2021). Obesity Aggravates Covid-19: A Systematic Review And Meta-Analysis. In Journal Of Medical Virology (Vol. 93, Number 1, Pp. 257–261). John Wiley And Sons Inc. Https://Doi.Org/10.1002/Jmv.26237




DOI: https://doi.org/10.33024/mnj.v8i9.12056

Refbacks

  • Saat ini tidak ada refbacks.